|Articles|June 30, 2016
AAHRPP Accredits Four More Research Organizations
Advertisement
WASHINGTON, D.C. - The Association for the Accreditation of Human Research Protection Programs today announced that it has accredited four more research organizations, including its first organizations in Africa and South America. The newly accredited organizations are:
- Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, Nanjing, Jiangsu, China
- Sociedade Beneficente Israelita Brasileira Albert Einstein, São Paulo, Brazil
- TREAD Research, Cape Town, South Africa
- Valley Health System, Ridgewood, New Jersey
“Even more important, however, is what these accreditations mean to the global research community,” she added. “In the U.S. and overseas, more and more organizations are committing to AAHRPP’s standards for research ethics, quality and safety. That’s good news for research participants, researchers, sponsors and all who ultimately will benefit from the discoveries that research makes possible.”  “Each of these accreditations represents a ‘first’ for us,” AAHRPP President and CEO Elyse I. Summers said. “Today we enthusiastically add great geographic and substantive diversity to our family of AAHRPP-accredited organizations, with our first organizations on the continents of Africa and South America, our first organization that focuses on traditional Chinese medicine and, believe it or not, our first accreditation in the state of New Jersey. To date, 231 organizations have earned AAHRPP accreditation. Of these, 35 are located outside the United States. To earn AAHRPP accreditation, organizations must demonstrate that they have built extensive safeguards into every level of their research operation and that they adhere to high standards for research. In today’s global, collaborative research enterprise, organizations increasingly rely on AAHRPP accreditation status to help identify trusted research partners. AAHRPP has accredited organizations in 47 states, Belgium, Brazil, Canada, China, India, Mexico, Republic of Korea, Saudi Arabia, Singapore, South Africa, Taiwan and Thailand.All major U.S. independent institutional review boards have earned AAHRPP accreditation. In addition, more than 60 percent of U.S. research-intensive universities and over 65 percent of U.S. medical schools are either AAHRPP accredited or have begun the accreditation process. The National Institutes of Health, the world’s largest public funder of research, has earned accreditation, as has Pfizer, Inc., the largest industry sponsor of clinical research.
About AAHRPP
A nonprofit organization, AAHRPP provides accreditation for organizations that conduct or review human research and can demonstrate that their protections exceed the safeguards required by the U.S. government. To learn more, visit
www.aahrpp.org
.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- eClinical Technology: Misconceptions, Challenges, and Opportunities
September 9th 2025
- How Sponsors Can Modernize Tools to Support Physicians
September 9th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
AstraZeneca’s Tagrisso Shows Landmark Overall Survival Benefit in Non-Small Cell Lung Cancer
2
Pfizer, BioNTech’s Comirnaty Shows Strong Immune Response in Phase III Trial for COVID-19
3
Phase III EMPOWER-Lung 3 Trial Confirms Five-Year Survival Benefit With Libtayo Plus Chemotherapy in NSCLC
4
Investigational OX40-Targetting T-Cell Therapy Shows Durable Efficacy Treating Atopic Dermatitis in Phase III Trial
5